Frontier Capital Management, an investment management company, released its “Frontier Small Cap Growth Fund” first quarter ...

Personalis and Tempus AI are adding colorectal cancer as a new indication to their existing commercialization agreement.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of its care pathway intelligence platform, ...

Tempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...

A high-level overview of Tempus AI, Inc. (TEM) stock. View (TEM) real-time stock price, chart, news, analysis, analyst reviews and more.

Needing a reliable car shipping company for your vehicle? Learn about Tempus Logix, including shipping options and availability, and read reviews.

One of the first actions by GSK's recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed at improving the big pharma's R&D productivity ...

Explore how AI-driven Smart Diagnostics are revolutionizing healthcare, as the market shifts from research to clinical practice. Discover the potential for premium diagnostics, pricing trends, and ...

Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.

Covid-19 exposed wide inequities in health in the United States and around the world. But health disparities persisted long before the pandemic. In this article the authors explain why businesses ...